Metagenomi, Inc. Common Stock
General ticker "MGX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $81.0M (TTM average)
Metagenomi, Inc. Common Stock follows the US Stock Market performance with the rate: 26.2%.
Estimated limits based on current volatility of 3.4%: low 1.30$, high 1.39$
Factors to consider:
- Total employees count: 236 as of 2023
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [1.29$, 3.17$]
- 2026-12-31 to 2027-12-31 estimated range: [1.28$, 3.12$]
Short-term MGX quotes
Long-term MGX plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $44.76MM | $52.30MM | $25.21MM |
| Operating Expenses | $123.25MM | $141.20MM | $121.22MM |
| Operating Income | $-78.49MM | $-88.90MM | $-96.01MM |
| Non-Operating Income | $18.26MM | $5.33MM | $8.09MM |
| R&D Expense | $94.40MM | $109.18MM | $94.43MM |
| Income(Loss) | $-60.23MM | $-83.57MM | $-87.93MM |
| Taxes | $8.03MM | $-5.51MM | $-0.06MM |
| Profit(Loss)* | $-68.25MM | $-78.06MM | $-87.87MM |
| Stockholders Equity | $215.17MM | $234.86MM | $158.60MM |
| Assets | $364.84MM | $324.60MM | $221.10MM |
| Operating Cash Flow | $-91.41MM | $-109.07MM | $-88.89MM |
| Capital expenditure | $9.81MM | $3.11MM | $0.57MM |
| Investing Cash Flow | $45.73MM | $-88.16MM | $103.53MM |
| Financing Cash Flow | $1.01MM | $84.01MM | $-0.36MM |
| Earnings Per Share** | $-1.82 | $-2.09 | $-2.36 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.